The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells. - Wikidata - wikimedia - TriplyDB

The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.

The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.

http://www.wikidata.org/entity/Q34078444

about

The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.Metastatic bone disease: role of transcription factors and future targets.The Role of RUNX2 in Osteosarcoma Oncogenesis.Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility Myeloma cell-derived Runx2 promotes myeloma progression in bone.Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1 Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.Inducible expression of Runx2 results in multiorgan abnormalities in mice.Molecular targets for radiation oncology in prostate cancer.Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.

P2860

Q26738703-6FF3F7CF-D1B2-4927-AE7A-6B1373BA6A4F Q26800112-9A718DBD-66B6-4155-8D9E-7AA768948197 Q28077461-A72AA866-5991-4BA2-BDEC-A03561733E68 Q33732391-0AD34CEC-F23C-4508-8F2A-CD46D74C1BB6 Q34217531-A85A16AC-B2C1-49FC-906A-0D95F6AEAF76 Q34423871-0AABEED2-A19C-4882-9727-0E486B51DEFD Q34989177-598DFC60-D770-4591-99C2-63731F765FA3 Q35692401-60470B77-12C2-4D4F-A221-36F855393C6F Q35762938-3AF0D0F7-CB1E-4337-BA23-7C1B908C47D7 Q35889495-5C277F81-E4E4-4711-BC8B-39A5B8C82D88 Q36157012-7E886405-30C1-4203-B396-607D8B98B089 Q36268283-CA1FCA9C-7ACC-4CC7-A2EC-67856C295614 Q36402883-31E64CB2-AD44-4B50-8118-A355ED377BFA Q37365273-D52A2795-430B-437E-B941-8593D398FD76 Q38014447-B6BF3434-0690-4172-85BC-883A1720418A Q38332288-15E369C9-499B-4598-9660-9A8EBAB93E37 Q42533014-B0F0F7FE-6B97-4151-89AE-9387C01A84FB Q47692014-1391F279-2717-4525-A7EF-8A4DC55B8BB7

P2860

The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.

http://www.wikidata.org/entity/Q34078444

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@ast

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@en

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@nl

type

label

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@ast

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@en

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@nl

prefLabel

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@ast

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@en

The cancer-related Runx2 prote ...... beta in prostate cancer cells.

@nl

P1433

Q34078444-8FB1861D-F0A3-44BA-9127-E3F1A6EBDA09

P1476

Q34078444-B58AF4C2-CA37-49E4-B481-8ACEC3C7968B

P2093

Q34078444-0476BCB3-8226-4D84-84D2-BB74D75C8F3C

Q34078444-17A30BBA-D5A0-4C44-9FA1-827BC239C1FE

Q34078444-3235EA08-D66D-4DF0-B2C2-E3EB8361C763

Q34078444-3D23B062-609B-4CCE-9C96-0BAE4D9DFA66

Q34078444-61394326-403A-4BCB-B12C-4983D9A6BF00

Q34078444-677FE4D4-8829-4A2B-B57D-813028DB1095

Q34078444-94B3935F-9B0A-4355-96D4-5B0A723D11E0

Q34078444-AB02B4EA-0934-4EF9-B4FE-6B6F71DB31AF

Q34078444-DD8B4D5D-CDA6-495F-9E3E-CC9BCEC591C9

P2860

Q34078444-02C0F6EB-7778-4187-97C7-B8B3618153B8

Q34078444-0503173F-5003-42EF-A914-2C277C20B39D

Q34078444-05EA894C-76DC-4071-9EEF-4B123A2B7CF9

Q34078444-0F41A969-5186-42F8-A448-10778C49F519

Q34078444-161A3DBE-9354-412E-95F7-C4EAAB20D483

Q34078444-16D47984-C691-4F29-9411-5912CD6C2E60

Q34078444-1B60945C-DFFB-4FF8-BAD2-33FEF0C2B112

Q34078444-1FFDB4E4-F488-4688-BC73-607144698F39

Q34078444-2B066D62-349A-4B10-8830-1A9262956EF9

Q34078444-306BD0A0-A63D-47EC-937B-A584A7F9B5C0

P304

Q34078444-EBC5635B-5EBC-4FC8-9B89-1E94F3265283

P31

Q34078444-B1A9575B-9D5E-4C35-9F1E-0F0E2964F07E

P356

Q34078444-3BFC17D1-B534-434B-864B-4F6CE6C7AF7C

P433

Q34078444-330C1591-FB2C-44AA-8E1F-2760CAF2F1F5

P478

Q34078444-D0A546C1-5D8E-4137-80EB-9B73B3856886

P50

Q34078444-EE842322-20B6-44E3-BF0B-D8B032DB3461

P577

Q34078444-02B50A7D-7EC6-47CD-A251-4F65FE230DF0

P5875

Q34078444-5B3E5419-A47C-4611-A625-7D9F80F3C7F6

P698

Q34078444-89264579-553B-4F5D-8CE5-DFD4DF92AF38

P932

Q34078444-D50581EF-F11B-4014-9FDB-1B2B922E8467

P356

P1433

Journal of Cellular Biochemistry

P1476

The cancer-related Runx2 prote ...... Fbeta in prostate cancer cells

@en

P2093

Andre J van Wijnen

http://www.w3.org/2001/XMLSchema#string

Dario C Altieri

http://www.w3.org/2001/XMLSchema#string

Gary S Stein

http://www.w3.org/2001/XMLSchema#string

Jacqueline Akech

http://www.w3.org/2001/XMLSchema#string

Jane B Lian

http://www.w3.org/2001/XMLSchema#string

Janet L Stein

http://www.w3.org/2001/XMLSchema#string

Margaretha van der Deen

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Thomas J FitzGerald

http://www.w3.org/2001/XMLSchema#string

P2860

CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P

Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA

The RUNX genes: gain or loss of function in cancer

Functional epigenomics identifies genes frequently silenced in prostate cancer

Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells.

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.

P304

828-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.22463

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Lucia R. Languino

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41041979

http://www.w3.org/2001/XMLSchema#string

P698

20082326

http://www.w3.org/2001/XMLSchema#string

P932

2925394

http://www.w3.org/2001/XMLSchema#string